Congratulations to Dr. Jeremiah Johnson for winning the prestigious Yosemite-ACS Award! Johnson received the award for his pioneering research on overcoming therapeutic resistance through cell-specific targeting of the tumor microenvironment with antibody-bottlebrush prodrug conjugates. This award, part of a $6 million grant initiative by the American Cancer Society and Yosemite, recognizes his dedication and innovative approach to cancer treatment.